Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial

Palumbo, Antonio; Bringhen, Sara; Marina Liberati, Anna; Caravita, Tommaso; Falcone, Antonietta; Callea, Vincenzo; Montanaro, Marco; Ria, Roberto; Capaldi, Antonio; Zambello, Renato; Benevolo, Giulia; Derudas, Daniele; Dore, Fausto; Cavallo, Federica; Gay, Francesca; Falco, Patrizia; Ciccone, Giovannino; Musto, Pellegrino; Cavo, Michèle; Boccadoro, Mario

doi:10.1182/blood-2008-04-149427

Public

Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial

Published in Blood • May 27, 2008

Authors:

Antonio Palumbo

Sara Bringhen

Anna Marina Liberati

Abstract

The initial analysis of the oral combination melphalan, prednisone, and thalidomide (MPT) in newly diagnosed patients with myeloma showed significantly higher response rate and longer progression-free survival (PFS) than did the standard melphalan and prednisone (MP) combination and suggested a surv...

Subject

Thalidomide

Medicine

Melphalan

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!